Recent News

Circassia abandons allergy programme after trial failure

British biotech Circassia has announced the death of its allergy programme following a second key trial failure, choosing to focus all of its efforts on its respiratory business instead.


Original Link...

Tags: medical, MEDICINE, pharmaceuticals
0 Volde

Read On: